Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

NACompletedINTERVENTIONAL

Enrollment

572

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Vulvovaginal Candidiasis

Interventions

DRUG

Terconazole Vaginal Suppository

Vaginal Suppository inserted intravaginally once daily before bedtime for 3 consecutive days

DRUG

Terazol Vaginal Suppository

Vaginal Suppository inserted intravaginally once daily before bedtime for 3 consecutive days